Trial Profile
The Efficacy of Targinact Treatment With Respect to Quality of Life (Overall Health Assessment) in Chronic Severe Pain Patients Compared to Previous Analgesic Treatment: a Non-interventional, Observational Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Oxycodone/naloxone (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors Mundipharma International
- 06 Nov 2013 Planned end date changed from 1 Dec 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 14 Nov 2012 New trial record